Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-25341
Publication type: | Article in scientific journal |
Type of review: | Peer review (publication) |
Title: | Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs : a propensity score matching study using real-world data |
Authors: | Höglinger, Marc Wirth, Brigitte Carlander, Maria Caviglia, Cornelia Frei, Christian Rhomberg, Birgitta Rohrbasser, Adrian Trottmann, Maria Eichler, Klaus |
et. al: | No |
DOI: | 10.1007/s10198-022-01486-2 10.21256/zhaw-25341 |
Published in: | The European Journal of Health Economics |
Issue Date: | 18-Jun-2022 |
Publisher / Ed. Institution: | Springer |
ISSN: | 1618-7601 1618-7598 |
Language: | English |
Subjects: | Diabetes; Disease management; Primary care; Program evaluation; Quality of care; Structured treatment program |
Subject (DDC): | 362.1041: Health economics 616: Internal medicine and diseases |
Abstract: | Objective: To evaluate the impact of a DMP for patients with diabetes mellitus in a Swiss primary care setting. Methods: In a prospective observational study, we compared diabetes patients in a DMP (intervention group; N?=?538) with diabetes patients receiving usual care (control group; N?=?5050) using propensity score matching with entropy balancing. Using a difference-in-difference (DiD) approach, we compared changes in outcomes from baseline (2017) to 1-year (2017/18) and to 2-year follow-up (2017/19). Outcomes included four measures for guideline-adherent diabetes care, hospitalization risk, and health care costs. Results: We identified a positive impact of the DMP on the share of patients fulfilling all measures for guideline-adherent care [DiD 2017/18: 7.2 percentage-points, p?<?0.01; 2017/19: 8.4 percentage-points, p?<?0.001]. The hospitalization risk was lower in the intervention group in both years, but only statistically significant in the 1-year follow-up [DiD 2017/18: – 5.7 percentage-points, p?<?0.05; 2017/19: – 3.9 percentage points, n.s.]. The increase in health care costs was smaller in the intervention than in the control group [DiD 2017/18: CHF – 852; 2017/19: CHF – 909], but this effect was not statistically significant. Conclusion: The DMP under evaluation seems to exert a positive impact on the quality of diabetes care, reflected in the increase in the measures for guideline-adherent care and in a reduction of the hospitalization risk in the intervention group. It also might reduce health care costs, but only a longer follow-up will show whether the observed effect persists over time. |
URI: | https://digitalcollection.zhaw.ch/handle/11475/25341 |
Fulltext version: | Published version |
License (according to publishing contract): | CC BY 4.0: Attribution 4.0 International |
Departement: | School of Management and Law |
Organisational Unit: | Winterthur Institute of Health Economics (WIG) |
Appears in collections: | Publikationen School of Management and Law |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2022_Hoeglinger-etal_Impact-diabetes-disease-management.pdf | 551.4 kB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.